These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31453247)

  • 1. A model for the detection of pancreatic ductal adenocarcinoma circulating tumor cells.
    Alexander MS; O'Leary BR; Moose D; Du J; Henry MD; Cullen JJ
    J Biol Methods; 2018; 5(3):e97. PubMed ID: 31453247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vivo Flow Cytometric Evaluation of Circulating Metastatic Pancreatic Tumor Cells after High-Intensity Focused Ultrasound Therapy.
    Yu Q; Yao Y; Zhu X; Gao Y; Chen Y; Wang R; Xu P; Wei X; Jiang L
    Cytometry A; 2020 Sep; 97(9):900-908. PubMed ID: 32307867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma.
    Poruk KE; Valero V; Saunders T; Blackford AL; Griffin JF; Poling J; Hruban RH; Anders RA; Herman J; Zheng L; Rasheed ZA; Laheru DA; Ahuja N; Weiss MJ; Cameron JL; Goggins M; Iacobuzio-Donahue CA; Wood LD; Wolfgang CL
    Ann Surg; 2016 Dec; 264(6):1073-1081. PubMed ID: 26756760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence- and multispectral optoacoustic imaging for an optimized detection of deeply located tumors in an orthotopic mouse model of pancreatic carcinoma.
    Napp J; Stammes MA; Claussen J; Prevoo HAJM; Sier CFM; Hoeben FJM; Robillard MS; Vahrmeijer AL; Devling T; Chan AB; de Geus-Oei LF; Alves F
    Int J Cancer; 2018 May; 142(10):2118-2129. PubMed ID: 29277891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-time in vivo imaging of subpopulations of circulating tumor cells using antibody conjugated quantum dots.
    Kuo CW; Chueh DY; Chen P
    J Nanobiotechnology; 2019 Feb; 17(1):26. PubMed ID: 30728024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression Profiling of Circulating Tumor Cells in Pancreatic Ductal Adenocarcinoma Patients: Biomarkers Predicting Overall Survival.
    Amantini C; Morelli MB; Nabissi M; Piva F; Marinelli O; Maggi F; Bianchi F; Bittoni A; Berardi R; Giampieri R; Santoni G
    Front Oncol; 2019; 9():874. PubMed ID: 31552188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Tumor Cells Expressing Markers of Tumor-Initiating Cells Predict Poor Survival and Cancer Recurrence in Patients with Pancreatic Ductal Adenocarcinoma.
    Poruk KE; Blackford AL; Weiss MJ; Cameron JL; He J; Goggins M; Rasheed ZA; Wolfgang CL; Wood LD
    Clin Cancer Res; 2017 Jun; 23(11):2681-2690. PubMed ID: 27789528
    [No Abstract]   [Full Text] [Related]  

  • 8. CTC phenotyping for a preoperative assessment of tumor metastasis and overall survival of pancreatic ductal adenocarcinoma patients.
    Sun Y; Wu G; Cheng KS; Chen A; Neoh KH; Chen S; Tang Z; Lee PF; Dai M; Han RPS
    EBioMedicine; 2019 Aug; 46():133-149. PubMed ID: 31375425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.
    Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N
    Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating Tumor Cells and Transforming Growth Factor Beta in Resected Pancreatic Adenocarcinoma.
    Vicente D; Lee AJ; Hall CS; Lucci A; Lee JE; Kim MP; Katz MHG; Hurd MW; Maitra A; Rhim Md AD; Tzeng CD
    J Surg Res; 2019 Nov; 243():90-99. PubMed ID: 31170555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating Tumor Cells Dynamics in Pancreatic Adenocarcinoma Correlate With Disease Status: Results of the Prospective CLUSTER Study.
    Gemenetzis G; Groot VP; Yu J; Ding D; Teinor JA; Javed AA; Wood LD; Burkhart RA; Cameron JL; Makary MA; Weiss MJ; He J; Wolfgang CL
    Ann Surg; 2018 Sep; 268(3):408-420. PubMed ID: 30080739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rapid and quantitative method to detect human circulating tumor cells in a preclinical animal model.
    Tu SH; Hsieh YC; Huang LC; Lin CY; Hsu KW; Hsieh WS; Chi WM; Lee CH
    BMC Cancer; 2017 Jun; 17(1):440. PubMed ID: 28645267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophils assist the metastasis of circulating tumor cells in pancreatic ductal adenocarcinoma: A new hypothesis and a new predictor for distant metastasis.
    Tao L; Zhang L; Peng Y; Tao M; Li L; Xiu D; Yuan C; Ma Z; Jiang B
    Medicine (Baltimore); 2016 Sep; 95(39):e4932. PubMed ID: 27684834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
    Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
    World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microfluidic Isolation of Circulating Tumor Cells and Cancer Stem-Like Cells from Patients with Pancreatic Ductal Adenocarcinoma.
    Varillas JI; Zhang J; Chen K; Barnes II; Liu C; George TJ; Fan ZH
    Theranostics; 2019; 9(5):1417-1425. PubMed ID: 30867841
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic significance of circulating tumor microemboli in patients with pancreatic ductal adenocarcinoma.
    Wu G; Zhu R; Li Y; Zhao Y; Dai M
    Oncol Lett; 2018 May; 15(5):7376-7382. PubMed ID: 29725451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-time monitoring of rare circulating hepatocellular carcinoma cells in an orthotopic model by in vivo flow cytometry assesses resection on metastasis.
    Fan ZC; Yan J; Liu GD; Tan XY; Weng XF; Wu WZ; Zhou J; Wei XB
    Cancer Res; 2012 May; 72(10):2683-91. PubMed ID: 22454286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Tumor Cells in Pancreatic Cancer: Current Perspectives.
    Martini V; Timme-Bronsert S; Fichtner-Feigl S; Hoeppner J; Kulemann B
    Cancers (Basel); 2019 Oct; 11(11):. PubMed ID: 31717773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of RARRES1 Expression on Circulating Tumor Cells as Unfavorable Prognostic Marker in Resected Pancreatic Ductal Adenocarcinoma Patients.
    Nitschke C; Markmann B; Tölle M; Kropidlowski J; Belloum Y; Goetz MR; Schlüter H; Kwiatkowski M; Sinn M; Izbicki J; Pantel K; Güngör C; Uzunoglu FG; Wikman H
    Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1.
    Chen H; Li L; Hu J; Zhao Z; Ji L; Cheng C; Zhang G; Zhang T; Li Y; Chen H; Pan S; Sun B
    J Exp Clin Cancer Res; 2019 Jul; 38(1):297. PubMed ID: 31288830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.